608 Morroniside activates the Nrf2/ARE pathway, upregulates GPX4, SLC7A11, FTH1, and FPN expression, increases GSH content, and decreases MDA and iron levels
MRI studies confirm the brain physically shrinks under sustained dehydration
The Dual Agonist Advantage: GLP-1 and GIP Unlike earlier medications that targeted only one pathway, tirzepatide is a novel dual agonist, mimicking the action of two naturally occurring incretin hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
lm chm qu trnh lo ha
Abstract The prevalence of type 2 diabetes (T2D) is increasing worldwide, with many patients developing long-term complications that affect their cardiovascular, urinary, alimentary, and other systems